Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Prostate Cancer Metastatic × Hematologic Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 10 Lung Neoplasms 8 Colorectal Neoplasms 7 Prostatic Neoplasms 6 Breast Neoplasms 5 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Stomach Neoplasms 2 Smoking Cessation 2 Motor Activity 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Stroke 1 Skin Neoplasms 1 Sezary Syndrome 1 Retroviridae Infections 1 Pulmonary Disease, Chronic Obstructive 1 Prostate Cancer Metastatic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Radiosurgery 5 Androgen Antagonists 4 enzalutamide 2 Prednisone 2 Docetaxel 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 olaparib 1 gallium 68 PSMA-11 1 darolutamide 1 cabazitaxel 1 apalutamide 1 XRP6258 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 Hematologic Tests 1 Granulocyte Colony-Stimulating Factor 1 Gonadotropin-Releasing Hormone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03223727 2023-04-18

ROTOR

The Netherlands Cancer Institute

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡